Clinical relevance of nanoparticle induced hyperthermia for drug delivery and treatment of abdominal cancers

Open Nanomedicine Journal

Volumn 3, Issue SPEC. ISSUE, 2011, Pages 24-37

  Levi Polyachenko, Nicole H ^a   Stewart IV, John H ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Hyperthermia; Intraperitoneal chemoperfusion; Nanoparticles

Indexed keywords

CARBON; CARBON NANOTUBE; CARBOPLATIN; CISPLATIN; DOUBLE WALLED NANOTUBE; DOXORUBICIN; ETOPOSIDE; FLOXURIDINE; FLUOROURACIL; FOLIC ACID; GEMCITABINE; GOLD NANOPARTICLE; IRON OXIDE; MELPHALAN; METAL NANOPARTICLE; MITOMYCIN C; MITOXANTRONE; MULTI WALLED NANOTUBE; NANOPARTICLE; OXALIPLATIN; PACLITAXEL; SINGLE WALLED NANOTUBE;

ABDOMINAL CANCER; CANCER CHEMOTHERAPY; COLORECTAL CANCER; CYTOREDUCTIVE SURGERY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; HEATED INTRAPERITONEAL CHEMOTHERAPY; HIGH TEMPERATURE; HUMAN; HYPERTHERMIC THERAPY; NONHUMAN; PERITONEAL DISEASE; PRIORITY JOURNAL; REVIEW; TUMOR ABLATION;

EID: 80051953642     PISSN: None     EISSN: 18759335     Source Type: Journal    
DOI: 10.2174/1875933501103010024     Document Type: Review

References (105)

1. American Cancer Society. Cancer facts and figures 2004. 1599 Clifton Rd. NE, Atlanta, GA, 30329, USA: Amer Can Soc 2004.
2. International Agency for Research on Cancer. 150 Cours Albert Thomas, 69372 Lyon CEDEX 08, France: World Health Org 2002.
3. Jemal A, Murray T, Ward E, et al. Cancer statistics. Ca-A Can J Clinicians 2005; 55(1): 10-30.
4. Levine EA, Stewart JH, Russell GB, Geisinger KR, Loggie BL, Shen P. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: Experience with 501 procedures. J Am Coll Surg 2007; 204(5): 943-53.
5. Oleson JR, Samulski TV, Leopold KA, et al. Sensitivity of hyperthermia trial outcomes to temperature and time - Implications for thermal goals of treatment. Int J Rad Onc Bio Phys 1993; 25(2): 289-97.
6. Hildebrandt B, Wust P, Ahlers O, et al. The cellular and molecular basis of hyperthermia. Crit Rev Onc Hematol 2002; 43(1): 33-56.
7. Sugarbaker PH, Mora JT, Carmignani P, Stuart OA, Yoo D. Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy. Oncologist 2005; 10(2): 112-22.
8. Rylander MN, Feng YS, Zhang YJ, et al. Optimizing heat shock protein expression induced by prostate cancer laser therapy through predictive computational models. J Biomed Optics 2006; 11(4).
9. Sugarbaker PH. How I do it - An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution. J Surg Onc 2005; 92(2): 142-6.
10. Schett G, Steiner CW, Xu Q, Smolen JS, Steiner G. TNF alpha mediates susceptibility to heat-induced apoptosis by protein phosphatase- mediated inhibition of the HSF1/hsp70 stress response. Cell Death Differ 2003; 10(10): 1126-36.
11. Rossi A, Ciafre S, Balsamo M, Pierimarchi P, Santoro MG. Targeting the heat shock factor 1 by RNA interference: A potent tool to enhance hyperthermochemotherapy efficacy in cervical cancer. Cancer Res 2006; 66(15): 7678-85.
12. Tu S, Mcstay GP, Boucher LM, Mak T, Beere HM, Green DR. In situ trapping of activated initiator caspases reveals a role for caspase-2 in heat shock-induced apoptosis. Nat Cell Bio 2006; 8(1): 72-U24.
13. Beere HM. Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J Clin Invest 2005; 115(10): 2633-9.
14. Gurbuxani S, Bruey JM, Fromentin A, et al. Selective depletion of inducible HSP70 enhances immunogenicity of rat colon cancer cells. Oncogene 2001; 20(51): 7478-85.
15. Yavelsky V, Vais O, Piura B, Wolfson M, Rabinovich A, Fraifeld V. The role of Hsp90 in cell response to hyperthermia. J Thermal Biol 2004; 29(7-8): 509-14.
16. Gabai VL, Zamulaeva IV, Mosin AF, et al. Resistance of Ehrlich tumor cells to apoptosis can be due to accumulation of heat shock proteins. FEBS Lett 1995; 375(1-2): 21-6.
17. Gabai VL, Kabakov AE. Induction of heat-shock protein synthesis and thermotolerance in EL-4 ascites tumor cells by transient ATP depletion after ischemic stress. Exp Mol Pathol 1994; 60(2): 88-99.
18. Garrido C, Gurbuxani S, Ravagnan L, Kroemer G. Heat shock proteins: Endogenous modulators of apoptotic cell death. Biochem Biophys Res Commun 2001; 286(3): 433-42.
19. Kiang JG, Tsokos GC. Heat shock protein 70 kDa: Molecular biology, biochemistry, and physiology. Pharmacol Therapeutics 1998; 80(2): 183-201.
20. Maroni P, Bendinelli P, Tiberio L, Rovetta F, Piccoletti R, Schiaffonati L. In vivo heat-shock response in the brain: signalling pathway and transcription factor activation. Mol Brain Res 2003; 119(1): 90-9.
21. Ravagnan L, Gurbuxani S, Susin SA, et al. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Bio 2001; 3(9): 839-43.
22. Ito A, Honda H, Kobayashi T. Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of heat-controlled necrosis with heat shock protein expression. Can Immunol Immunother 2006; 55(3): 320-8.
23. Aalinkeel R, Bindukumar B, Reynolds JL, et al. The Dietary bioflavonoid, quercetin, selectively induces apoptosis of Prostate cancer cells by down-regulating the expression of heat shock protein 90. Prostate 2008; 68(16): 1773-89.
24. Jakubowicz-Gil J, Paduch R, Piersiak T, Glowniak K, Gawron A, Kandefer-Szerszen M. The effect of quercetin on pro-apoptotic activity of cisplatin in HeLa cells. Biochem Pharmacol 2005; 69(9): 1343-50.
25. Rong Y, Yang EB, Zhang K, Mack P. Quercetin-induced apoptosis in the monoblastoid cell line U937 in vitro and the regulation of heat shock proteins expression. Anticancer Res 2000; 20(6B): 4339-45.
26. Sharma H, Sen S, Singh N. Molecular pathways in the chemosensitization of cisplatin by quercetin in human head and neck cancer. Can Bio Therapy 2005; 4(9): 949-55.
27. Wenzel U, Herzog A, Kuntz S, Daniel H. Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells. Proteomics 2004; 4(7): 2160-74.
28. Carmignani L, Gadda F, Gazzano G, et al. High incidence of benign testicular neoplasms diagnosed by ultrasound. J Urol 2003; 170(5): 1783-6.
29. Averbach AM, Sugarbaker PH. Recurrent intraabdominal cancer with intestinal-obstruction. Int Surg 1995; 80(2): 141-6.
30. Eggermont AMM, Steller EP, Sugarbaker PH. Laparotomy enhances intraperitoneal tumor-growth and abrogates the antitumor effects of Interleukin-2 and lymphokine-activated killer-cells. Surgery 1987; 102(1): 71-8.
31. Varban O, Levine EA, Stewart JH, Mccoy TP, Shen P. Outcomes associated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in colorectal cancer patients with peritoneal surface disease and hepatic metastases. Cancer 2009; 115(15): 3427-36.
32. Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21(20): 3737-43.
33. Dedrick RL, Flessner MF. Pharmacokinetic problems in peritoneal drug administration: Tissue penetration and surface exposure. J National Cancer Inst 1997; 89(7): 480-7.
34. Dedrick RL. Interspecies scaling of regional drug delivery. J Pharm Sci 1986; 75(11): 1047-52.
35. Flessner MF, Fenstermacher JD, Dedrick RL, Blasberg RG. A distributed model of peritoneal-plasma transport - tissue concentration gradients. Am J Physiol 1985; 248(3): 425-435.
36. Bartlett DL, Buell JF, Libutti SK, et al. A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis. Cancer 1998; 83(10): 2241.
37. Ozols RF, Young RC, Speyer JL, et al. Phase-1 and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian-cancer. Cancer Res 1982; 42(10): 4265-9.
38. Kuzuya T, Yamauchi M, Ito A, Hasegawa M, Hasegawa T, Nabeshima T. Pharmacokinetic characteristics of 5-fluorouracil and mitomycin-C in intraperitoneal chemotherapy. J Pharm Pharmacol 1994; 46(8): 685-9.
39. Speyer JL, Collins JM, Dedrick RL, et al. Phase-I and pharmacological studies of 5-fluorouracil administered intraperitoneally. Cancer Res 1980; 40(3): 567-72.
40. Israel VK, Jiang C, Muggia FM, et al. Intraperitoneal 5-fluoro-2'- deoxyuridine (Fudr) and (S)-leucovorin for disease predominantly confined to the peritoneal-cavity - A pharmacokinetic and toxicity study. Cancer Chemother Pharmacol 1995; 37(1-2): 32-8.
41. Markman M, Brady MF, Spirtos NM, Hanjani P, Rubin SC. Phase II trial of intraperitoneal paclitaxel in carcinoma of the ovary, tube, and peritoneum: A gynecologic oncology group study. J Clin Oncol 1998; 16(8): 2620-4.
42. Stewart JH, Shen P, Russell G, et al. A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers. Ann Surg Oncol 2008; 15(8): 2137-45.
43. Stewart JH, Shen P, Levine EA. Translation considerations for hyperthermic intraperitoneal chemotherapy. Curr Probl Cancer 2009; 33(3): 194-202.
44. Hirsch LR, Gobin AM, Lowery AR, et al. Metal nanoshells. Ann Biomed Eng 2006; 34(1): 15-22.
45. Shenoy DB, Amiji MA. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Int J Pharmaceutics 2005; 293(1-2): 261-70.
46. Reddy LH. Drug delivery to tumours: recent strategies. J Pharm Pharmacol 2005; 57(10): 1231-42.
47. Portney NG, Ozkan M. Nano-oncology: drug delivery, imaging, and sensing. Anal Bioanal Chem 2006; 384(3): 620-30.
48. Kroto HW, Heath JR, Obrien SC, Curl RF, Smalley RE. C-60 - Buckminsterfullerene. Nature 1985; 318(6042): 162-3.
49. Ely JL, Emken MR, Accuntius JA, et al. Pure pyrolytic carbon: Preparation and properties of a new material, On-X (R) carbon for mechanical heart valve prostheses. J Heart Valve Dis 1998; 7(6): 626-32.
50. Goodman SL, Tweden KS, Albrecht RM. Platelet interaction with pyrolytic carbon heart-valve leaflets. J Biomed Mater Res 1996; 32(2): 249-58.
51. Dresselhaus MS, Dresselhaus G, Charlier JC, Hernandez E. Electronic, thermal and mechanical properties of carbon nanotubes. Philosophical Trans Royal Soc London Series A-Math Phys Eng Sci 2004; 362(1823): 2065-98.
52. Carrero-Sanchez JC, Elias AL, Mancilla R, et al. Biocompatibility and toxicological studies of carbon nanotubes doped with nitrogen. Nano Lett 2006; 6(8): 1609-16.
53. Liu JW, Webster S, Carroll DL. Temperature and flow rate of NH3 effects on nitrogen content and doping environments of carbon nanotubes grown by injection CVD method. J Phys Chem B 2005; 109(33): 15769-74.
54. Misra A, Tyagi PK, Singh MK, Misra DS. FTIR studies of nitrogen doped carbon nanotubes. Diamond Relat Mat 2006; 15(2-3): 385-8.
55. Xu JF, Xiao M, Czerw R, Carroll DL. Optical limiting and enhanced optical nonlinearity in boron-doped carbon nanotubes. Chem Phys Lett 2004; 389(4-6): 247-50.
56. Hepplestone SP, Ciavarella AM, Janke C, Srivastava GP. Size and temperature dependence of the specific heat capacity of carbon nanotubes. Surf Sci 2006; 600(18): 3633-6.
57. Iijima S. Helical microtubules of graphitic carbon. Nature 1991; 354(6348): 56-8.
58. Mittal JP. Excited-states and electron-transfer reactions of fullerenes. Pure App Chem 1995; 67(1): 103-10.
59. Sears A, Batra RC. Buckling of multiwalled carbon nanotubes under axial compression. Phys Rev B 2006; 73(8).
60. Wang X, Sun B, Yang HK. Stability of multi-walled carbon nanotubes under combined bending and axial compression loading. Nanotechnology 2006; 17(3): 815-23.
61. Kouklin N, Tzolov M, Straus D, Yin A, Xu JM. Infrared absorption properties of carbon nanotubes synthesized by chemical vapor deposition. Appl Phys Lett 2004; 85(19): 4463-5.
62. Torti S, Byrne F, Whelan O, et al. Thermal ablation therapeutics based on CNx multi-walled nanotubes. Int J Nanomed 2007; 2(4).
63. Kam NWS, O'Connell M, Wisdom JA, Dai HJ. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc Natl Acad Sci USA 2005; 102(33): 11600-5.
64. Menna E, Scorrano G, Maggini M, et al. Shortened single-walled nanotubes functionalized with poly(ethylene glycol): preparation and properties. Arkivoc 2003; 64-73.
65. Sinani VA, Gheith MK, Yaroslavov AA, et al. Aqueous dispersions of single-wall and multiwall carbon nanotubes with designed amphiphilic polycations. J Am Chem Soc 2005; 127(10): 3463-72.
66. Tkac J, Ruzgas T. Dispersion of single walled. carbon nanotubes. Comparison of different dispersing strategies for preparation of modified electrodes toward hydrogen peroxide detection. Electrochem Comm 2006; 8(5): 899-903.
67. Terrones M. Science and technology of the twenty-first century: Synthesis, properties and applications of carbon nanotubes. Ann Rev Mat Res 2003; 33: 419-501.
68. Belin T, Epron R. Characterization methods of carbon nanotubes: a review. Mat Sci Eng B-Solid State Mat Adv Technol 2005; 119(2): 105-18.
69. Bandow S, Asaka S, Saito Y, et al. Effect of the growth temperature on the diameter distribution and chirality of single-wall carbon nanotubes. Phys Rev Lett 1998; 80(17): 3779-82.
70. Saito R, Gruneis A, Samsonidze GG, et al. Optical absorption of graphite and single-wall carbon nanotubes. App Phys A-Mat Sci Process 2004; 78(8): 1099-105.
71. Bachilo SM, Strano MS, Kittrell C, Hauge RH, Smalley RE, Weisman RB. Structure-assigned optical spectra of single-walled carbon nanotubes. Science 2002; 298(5602): 2361-6.
72. O'Connell MJ, Bachilo SM, Huffman CB, et al. Band gap fluorescence from individual single-walled carbon nanotubes. Science 2002; 297(5581): 593-6.
73. Casey A, Farrell GF, McNamara M, Byrne1 HJ, Chambers G. Interaction of carbon nanotubes with sugar complexes. Synth Met 2005; 153(1-3): 357-60.
74. Maksimenko SA, Slepyan GY, Nemilentsau AM, Shuba MV. Carbon nanotube antenna: Far-field, near-field and thermal-noise properties. Physica E: Low-dim Sys Nanostructures 2008; 40(7): 2360-4.
75. Dresselhaus MS, Eklund PC. Phonons in carbon nanotubes. Advances Phys 2000; 49(6): 705-814.
76. Hepplestone SP, Srivastava GP. The intrinsic lifetime of lowfrequency zone-centre phonon modes in silicon nanowires and carbon nanotubes. Appl Surf Sci 2006; 252(21): 7726-9.
77. Kempa K, Rybczynski J, Huang ZP, et al. Carbon nanotubes as optical antennae. Adv Mat 2007; 19(3): 421-6.
78. Wang Y, Kempa K, Kimball B, et al. Receiving and transmitting light-like radio waves: Antenna effect in arrays of aligned carbon nanotubes. App Phys Lett 2004; 85(13): 2607-9.
79. Hanson GW. Fundamental transmitting properties of carbon nanotube antennas. IEEE Trans Antennas Propag 2005; 53(11): 3426-35.
80. Burke PJ, Li SD, Yu Z. Quantitative theory of nanowire and nanotube antenna performance. IEEE Trans Nanotechnol 2006; 5(4): 314-34.
81. Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol 2001; 19: 319.
82. Braun C, Smirnov S. Why is water blue. J Chemical Educ 1993; 70(8): 612.
83. Launay S, Fedorov AG, Joshi Y, Cao A, Ajayan PM. Hybrid micro- nano structured thermal interfaces for pool boiling heat transfer enhancement. Microelectronics J 2006 Nov; 37(11): 1158-64.
84. Park KJ, Jung D. Enhancement of nucleate boiling heat transfer using carbon nanotubes. Int J Heat Mass Transfer 2007; 50(21-22): 4499-502.
85. Zhang HL, Chen ZQ. Nanobomb: A potential technique for in vivo imaging and targeted cancer cell destruction. Med Hypotheses 2009; 73(5): 864-5.
86. Lee Y, Park SY, Kim C, Park TG. Thermally triggered intracellular explosion of volume transition nanogels for necrotic cell death. J Cont Rel 2009; 135(1): 89-95.
87. Gannon CJ, Cherukuri P, Yakobson BI, et al. Carbon nanotubeenhanced thermal destruction of cancer cells in a noninvasive radiofrequency field. Cancer 2007; 110(12): 2654-65.
88. Burke A, Ding XF, Singh R, et al. Long-term survival following a single treatment of kidney tumors with multi-walled carbon nanotubes and near-infrared radiation. Proc Natl Acad Sci USA 2009; 106(31): 12897-902.
89. Levi-Polyachenko NH, Merkel EJ, Jones BT, Carroll DL, Stewart JH. Rapid photothermal intracellular drug delivery using multiwalled carbon nanotubes. Mol Pharm 2009; 6(4): 1092-9.
90. Tong L, Zhao Y, Huff TB, Hansen MN, Wei A, Cheng JX. Gold nanorods mediate tumor cell death by compromising membrane integrity. Adv Mat 2007; 19(20): 3136-41.
91. Liu Z, Chen K, Davis C, et al. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res 2008; 68(16): 6652-60.
92. Liu Z, Cai WB, He LN, et al. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat Nanotechnol 2007; 2(1): 47-52.
93. Zhang XK, Meng LJ, Lu QG, Fei ZF, Dyson PJ. Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes. Biomaterials 2009; 30(30): 6041-7.
94. Purushotham S, Ramanujan RV. Thermoresponsive magnetic composite nanomaterials for multimodal cancer therapy. Acta Biomat 2010; 6(2): 502-10.
95. Jain PK, Lee KS, El-Sayed IH, El-Sayed MA. Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: Applications in biological imaging and biomedicine. J Phys Chem B 2006; 110(14): 7238-48.
96. Roper DK, Ahn W, Hoepfner M. Microscale heat transfer transduced by surface plasmon resonant gold nanoparticles. J Phys Chem C 2007; 111(9): 3636-41.
97. Brown SC, Kamal M, Nasreen N, et al. Influence of shape, adhesion and simulated lung mechanics on amorphous silica nanoparticle toxicity. Adv Powder Technol 2007; 18(1): 69-79.
98. Jahnen-Dechent W, Simon U. Function follows form: shape complementarity and nanoparticle toxicity. Nanomedicine 2008; 3(5): 601-3.
99. Powers KW, Palazuelos M, Moudgil BM, Roberts SM. Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies. Nanotoxicology 2007; 1(1): 42-51.
100. Wang SG, Lu WT, Tovmachenko O, Rai US, Yu HT, Ray PC. Challenge in understanding size and shape dependent toxicity of gold nanomaterials in human skin keratinocytes. Chem Phys Lett 2008; 463(1-3): 145-9.
101. Decuzzi P, Pasqualini R, Arap W, Ferrari M. Intravascular delivery of particulate systems: Does geometry really matter? Pharm Res 2009; 26(1): 235-43.
102. Decuzzi P, Lee S, Decuzzi M, Ferrari M. Adhesion of microfabricated particles on vascular endothelium: A parametric analysis. Ann Biomed Eng 2004; 32(6): 793-802.
103. Serda RE, Go JH, Bhavane RC, et al. The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. Biomaterials 2009; 30(13): 2440-8.
104. Kim JW, Galanzha EI, Shashkov EV, Moon HM, Zharov VP. Golden carbon nanotubes as multimodal photoacoustic and photothermal high-contrast molecular agents. Nat Nanotechnol 2009; 4(10): 688-94.
105. Wu GH, Milkhailovsky A, Khant HA, Fu C, Chiu W, Zasadzinski JA. Remotely triggered liposome release by near-infrared light absorption via hollow gold nanoshells. J Am Chem Soc 2008; 130(26): 8175-7.